Dose escalation with overdose control using a quasi-continuous toxicity score in cancer Phase I clinical trials.
about
Escalation with overdose control using all toxicities and time to event toxicity data in cancer Phase I clinical trials.Dose finding with drug combinations in cancer phase I clinical trials using conditional escalation with overdose control.Approaches for informing optimal dose of behavioral interventions.Adaptive Estimation of Personalized Maximum Tolerated Dose in Cancer Phase I Clinical Trials Based on All Toxicities and Individual Genomic ProfileInteractive Software "Isotonic Design using Normalized Equivalent Toxicity Score (ID-NETS©TM)" for Cancer Phase I Clinical Trials.An Escalation for Bivariate Binary Endpoints Controlling the Risk of Overtoxicity (EBE-CRO): Managing Efficacy and Toxicity in Early Oncology Clinical Trials.How to keep high-risk studies ethical: classifying candidate solutions.Escalation with overdose control for phase I drug-combination trials.A Bayesian adaptive design for cancer phase I trials using a flexible range of doses.Nonparametric overdose control with late-onset toxicity in phase I clinical trials.Dose Finding for Drug Combination in Early Cancer Phase I Trials using Conditional Continual Reassessment Method.Escalation with Overdose Control Using Ordinal Toxicity Grades for Cancer Phase I Clinical TrialsMethodology and Application of Adaptive and Sequential Approaches in Contemporary Clinical Trials
P2860
Q30757656-A8C3D60D-6496-4A62-9E9D-7C2674A3A3E5Q34143140-16F4C05C-E6FA-4BCA-9F58-1B7AF40F255BQ35551665-2B4CACAE-863A-46AB-9948-E026E2C73A48Q36261042-2EB35977-D202-45DC-BA74-070C2AA4CC78Q36924666-F41F3BB2-3A8E-485E-869A-70E9B7351E7EQ38735192-091FB398-E83D-4686-8D54-B8650F2C4C4FQ42355200-2C2E2B5B-68AE-428A-A246-FD3D9895C13BQ45834856-165D1683-04FC-4333-A675-150FA0D2F645Q50246047-C6B45529-44EE-4FD5-B3FF-54CEC6E52CC7Q50593013-B0C3871C-B58D-46AB-935B-04B8A6A0E581Q54957800-88412DB0-7B17-4170-B383-359D78CE063DQ58910958-1706DFDD-BBF1-4A4A-A139-86C25BFEC268Q58910970-F1914F6F-C141-4DD7-A1FD-4A894F293275
P2860
Dose escalation with overdose control using a quasi-continuous toxicity score in cancer Phase I clinical trials.
description
2012 nî lūn-bûn
@nan
2012 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
name
Dose escalation with overdose ...... ancer Phase I clinical trials.
@ast
Dose escalation with overdose ...... ancer Phase I clinical trials.
@en
type
label
Dose escalation with overdose ...... ancer Phase I clinical trials.
@ast
Dose escalation with overdose ...... ancer Phase I clinical trials.
@en
prefLabel
Dose escalation with overdose ...... ancer Phase I clinical trials.
@ast
Dose escalation with overdose ...... ancer Phase I clinical trials.
@en
P2093
P2860
P1476
Dose escalation with overdose ...... ancer Phase I clinical trials.
@en
P2093
Jeanne Kowalski
Mourad Tighiouart
Zhengjia Chen
P2860
P304
P356
10.1016/J.CCT.2012.04.007
P407
P577
2012-04-25T00:00:00Z